Form 4: Gaurav Aggarwal, Geron Corp Director, Reports Stock Option Grant

Director Gaurav Aggarwal reports the acquisition of stock options in Geron Corp.

Summary

• Gaurav Aggarwal, a director of Geron Corp, filed a Form 4 with the SEC.
• The filing reports the acquisition of stock options to purchase 180,000 shares of Geron Corp common stock.
• The options were granted on May 21, 2025, with an exercise price of $1.34.
• The options vest on the earlier of the next annual meeting of the Issuer's stockholders or the first anniversary of the grant date, subject to continuous service.
• Following the transaction, Aggarwal directly owns derivative securities for 180,000 shares.

Sentiment

Score: 6

Explanation: The document is a routine filing related to stock option grants, which is generally neutral. It indicates alignment of interests between management and shareholders, which is mildly positive.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service with the company.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning the director's interests with the company's performance.

Key Dates

Keywords

Form 4, Geron Corp, Stock Options, Director, Beneficial Ownership, Aggarwal, GERN